Press Release

Global Radiofrequency Ablation Systems Market Sees Robust Growth on Cards with Increasing Preference Towards Minimally Invasive Surgeries

The expanding pervasiveness of malignant growth and rising interest for treating such perpetual infections are moving the worldwide radiofrequency removal frameworks showcase, discovers Fortune Business Insights in their ongoing examination. The study is titled, “Radiofrequency Ablation Systems Market: Global Market Analysis, Insights, and Forecasts, 2018 – 2025.” The market, as per the study, will exhibit growth at a promising CAGR on account of the rising prevalence of both cardiovascular and chronic diseases around the world.

Fortune Business Insight forecasts the oncology segment to hold a considerable share in the market with respect to applications. This is owing to the higher adoption of radiofrequency ablation devices in the treatment of cancer in both developed and developing nations. 

Sample PDF Brochure https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/radiofrequency-ablation-systems-market-100213 

Gradual Shift Towards Minimally Invasive Procedures Fuels Demand for Radiofrequency Ablation Devices

In 2017, clinical research stated that radiofrequency ablation therapies increase the probability of curing cancer by an estimated percentage of 40.0%. In addition to this, nearly 60% of cancer patients undergo radiotherapies. Radiofrequency ablation process destroys the tissues that cause cancer and using this non-surgical method also destroys the nerves that send pain signals to the brain. Thus, patient preference for radiofrequency ablation is increasing and this will drive the market in the coming years.

Radiofrequency ablation technique uses heat for killing cancer cells and interrupts pain signals sent to the brain by the affected nerves. It is used during cardiac procedures, for eliminating tumors and during chronic pain. It is preferred more as compared to other surgical procedures and is completely safe. Such factors bode well for the market during the forecast period.

The rising geriatric population and their susceptibility towards various chronic and cardiovascular diseases are boosting the global market for radiofrequency ablation systems market.  Besides this, patients are gradually shifting to minimally invasive procedures from conventional procedures and this will help the market earn more revenues during the forecast period.

However, the market may face challenges in terms of high maintenance cost and lower accessibility in developing nations. This coupled with, the lack of awareness about such painless procedures may restrict the market’s growth. Furthermore, the availability of other treatment methods may cause hindrance to the radiofrequency ablation system market in the long run.

Nevertheless, the high effectiveness of radiofrequency ablation techniques and short time span for treatment procedure take will provide lucrative growth opportunities for the market during the forecast period.

Browse Complete Report Details at https://www.fortunebusinessinsights.com/industry-reports/radiofrequency-ablation-systems-market-100213

Emerging Nations to Exhibit High Demand for Radiofrequency Ablation Systems in Market

The rise in prevalence of chronic diseases such as chronic neck and back pain, cardiac arrest, and cancer is helping North America to emerge dominant. This, accompanied by the need for safe surgical procedures and adoption of non-invasive surgical procedures will help North America to continue dominating the market in the coming years. On the other side, the market for radiofrequency ablation in Asia Pacific and the Middle East and Africa are expected to have great potential for growth. This is due to the increasing prevalence of cancer and the need for providing remedial measures in the developing nations of the respective regions.

Some of the companies operating in the region are;

  • Johnson & Johnson Services, Inc.
  • RF MEDICAL
  • AtriCure, Inc.
  • ENDO-FLEX GmbH
  • Bramsys Indústria e Comércio Ltda.
  • Gynesonics, Inc.
  • Medtronic, Boston Scientific Corporation
  • Hologic Inc.
  • RZ Medizintechnik
  • Sutter Medizintechnik GmbH
  • AngioDynamics
  • Stryker, and Abbott.

View More Reports

Tags

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Close